Capai PLC
CPAI · Main Market · Financial Services · mcap £1.7m · 0.4p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 07 Aug 26 | Clarification Re: Admission of Ordinary Shares
capAI plc (LSE: CPAI, OTCQB: CPIQF) (the "Company") refers to its announcements dated 7 May 2026 regarding the exercise of warrants and 5 August 2026 regarding the Company's £280,000 fundraise (the "Fundraise"). |
+2.0% | |
| 05 Aug 26 | Fundraise | Fundraise
MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN FROM CERTAIN PERSONS IN RELATION TO THE FUNDRAISE (AS DEFINED BELOW). |
−13.3% |
| 23 Jul 26 | Licence and Option Agreement for Ageotype
Execution of Licence and Option Agreement with R42 Group for Ageotype Longevity Platform |
+35.1% | |
| 09 Jul 26 | Extension of Licence and Option Agreements
Extension of Licence and Option Agreements for Author42, Movie42 and Gamers42 |
−2.4% | |
| 30 Jun 26 | Results | Half-year Results
(the "Company" and, together with its subsidiaries, the "Group" or "capAI") |
+4.5% |
| 16 Jun 26 | Board change | CapAI Chairman Professor Ronjon Nag Awarded OBE
(the "Company" and, together with its subsidiaries, the "Group" or "capAI") |
+5.6% |
| 09 Jun 26 | CapMedia Platform Portfolio Update and Webinar
(the "Company" and, together with its subsidiaries, the "Group" or "capAI") |
+11.5% | |
| 07 May 26 | Exercise of Warrants
capAI plc (LSE: CPAI, OTCQB: CPIQF) announces that it has received notice of exercise of warrants ("Warrants") to subscribe for a total of 5,290,000 new ordinary shares of nominal value £0.0001 each in the capital of the |
−14.6% | |
| 21 Apr 26 | AGM Trading & Strategic Update
(the "Company" and, together with its subsidiaries, the "Group" or "capAI") |
+57.5% | |
| 10 Feb 26 | Fundraise | Commercial and Strategy Update, Fundraising
MARKET SOUNDINGS WERE TAKEN FROM CERTAIN PERSONS IN RELATION TO THE FUNDRAISE (AS DEFINED BELOW). |
+7.3% |
| 30 Jan 26 | Results | Final Results
I am pleased to present the Annual Report and Financial Statements of capAI plc for the year ended 30 September 2025. |
+8.6% |
| 17 Dec 25 | Board and Committee Changes
capAI plc (LSE: CPAI) is pleased to announce that Jack Allardyce has been appointed to the board of directors of the Company ("Board") as an Executive Director. |
−1.9% | |
| 18 Nov 25 | Soft Launch of Author42
capAI plc (LSE: CPAI; OTCQB: CPIQF) is pleased to announce the soft launch of Author42, an advanced generative‑AI platform designed to revolutionise non-fiction book creation for authors, editors and publishing teams. |
−5.3% | |
| 05 Nov 25 | Commencement of Trading on OTCQB Venture Market
(the "Company" and together with its subsidiaries from time to time, the "Group" or "capAI") |
+9.0% | |
| 04 Nov 25 | Exercise of Warrants, TVR and Other Updates
Exercise of Warrants, Total Voting Rights, Grant of Conditional Awards / Share Options and Appointment of Corporate Broker |
−8.3% | |
| 15 Oct 25 | Delivery of Completion Notice for Creator42
Delivery of Completion Notice for Creator42 Licence and Option Agreement |
+11.1% | |
| 14 Oct 25 | Move to SETS Trading Platform
capAI (LSE: CPAI) is pleased to announce that trading in the Company's ordinary shares of nominal value £0.0001 each ("Ordinary Shares") on the main market for listed securities of London Stock Exchange plc (the "LSE") s |
−3.1% | |
| 08 Oct 25 | Director dealing | Director/PDMR and PCA Shareholdings
capAI (LSE: CPAI) announces that it was notified on 8 October 2025 of the following transactions: |
−3.0% |
| 07 Oct 25 | Incorporation of capMedical Inc and Other Updates
Incorporation of capMedical Inc, Renaming of UK Subsidiaries |
+5.3% | |
| 06 Oct 25 | Results | Results of GM, Share Consolidation and TVR
Results of General Meeting, Share Consolidation and Total Voting Rights |
−0.6% |
Company filings. Not investment advice.